Vice President of Clinical Operations
Liz has over 30 years’ experience in Clinical Operations and Clinical Development across the pharmaceutical and CRO industries, with experience across all phases of development.
Liz started her career as a CRA with SmithKline Beecham and has since held positions of increasing responsibility within SB and subsequently with Covance, Johnson and Johnson, Syngenta and Actelion. Most recently she was Senior Director, Clinical Operations at Allergan and subsequently Country Head for the UK for PSI-CRO.
Throughout her career Liz has managed clinical programs from early phase entry into man and proof of concept through to global Phase 3 registration projects, managing teams and activities performed both in-house and in a full or part outsourced model.
Liz was also VP Clinical Operations at KaNDy Therapeutics, a Women’s Health company. KaNDy was acquired by Bayer Pharmaceuticals in September 2020.